Pneumology

Maria Molina Molina / Jordi Dorca Sargatal
PRINCIPAL INVESTIGATORS
  • Guillermo Rafael Suarez Cuartin
  • Noelia Cubero Frutos
  • Rosa Maria Lopez Lisbona
  • Mariana Mercedes Muñoz Esquerre
  • Jesus Ribas Sola
  • Ana Cordoba Izquierdo
  • Vanesa Vicens Zygmunt
  • Maria Dela Salud Santos Perez
  • Eva Farrero Muñoz
CLINICAL RESEARCHERS
  • Carmen Monasterio Ponsa
  • Roger Llatjos Sanuy
  • Marta Lopez Sanchez
  • Neus Salord Oleo
  • Susana Padrones Sanchez
  • Enric Prats Soro
  • Rosa Planas Balague
POSTDOCTORAL RESEARCHERS
  • Ana Montes Worboys
PREDOCTORAL RESEARCHERS
  • Yolanda Ruiz Albert
  • Carlos Esteban Machahua Huamani
  • Ester Cuevas Sales
  • Lurdes Planas Cerezales
  • Samantha Aso Gonzalez
  • Merce Gasa Galmes
SCIENTIFIC SUPPORT
  • Jesus Rios Martin
  • Montserrat Navarro Rodriguez
  • Maria Jose Rodriguez Lopez
MANAGEMENT SUPPORT
  • Jessica Germaine Shull
  • Maria Del Mar Chicote Guerra
Translational Medicine
Cardiovascular, Respiratory and Systemic Diseases and cellular aging

Scientific production

44

PAPERS

Impact factor: 214,268

3 PUBLICATIONS IN FIRST DECILE

20 PUBLICATIONS IN FIRST QUARTILE

25 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Machahua C, Buendia Roldan I, Ocana Guzman R, Molina M, Pardo A, Chavez Galan L, Selman M. CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile. Thorax. 2021;76(2):152-160. doi:10.1136/thoraxjnl-2020-215520. IF:9,14.
  • Shull JG, Pay MT, Compte CL, Olid M, Bermudo G, Portillo K, Sellares J, Balcells E, Vicens Zygmunt V, Planas Cerezales L, Badenes Bonet D, Blavia R, Rivera Ortega P, Moreno A, Sans J, Perich D, Barril S, Esteban L, Garcia Bellmunt L, Esplugas J, Suarez Cuartin G, Bordas Martinez J, Castillo D, Jolis R, Salvador I, Anton SE, Villar A, Robles Perez A, Cardona MJ, Barbeta E, Silveira MG, Guevara C, Dorca J, Rosell A, Luburich P, Llatjos R, Jorba O, Molina M. Mapping IPF helps identify geographic regions at higher risk for disease development and potential triggers. Respirology. 2021;26(4):352-359. doi:10.1111/resp.13973. IF:6,42.
  • Suarez Cuartin G, Gasa M, Bermudo G, Ruiz Y, Hernandez Argudo M, Marin A, Trias Sabria P, Cordoba A, Cuevas E, Sarasate M, Ariza A, Sabater J, Romero N, Subirana C, Molina M, Santos S. Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care Unit. Front. Med. 2021;8711027-711027. doi:10.3389/fmed.2021.711027. IF:5,09.
  • Planas Cerezales L, Arias Salgado EG, Berastegui C, Montes Worboys A, Gonzalez Montelongo R, Lorenzo Salazar JM, Vicens Zygmunt V, Garcia Moyano M, Dorca J, Flores C, Perona R, Roman A, Molina M. Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction. Front. Med. 2021;8695919-695919. doi:10.3389/fmed.2021.695919. IF:5,09.
  • Keir HR, Shoemark A, Dicker AJ, Perea L, Pollock J, Giam YH, Suarez Cuartin G, Crichton ML, Lonergan M, Oriano M, Cant E, Einarsson GG, Furrie E, Elborn JS, Fong CJ, Finch S, Rogers GB, Blasi F, Sibila O, Aliberti S, Simpson JL, Huang JTJ, Chalmers JD. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med. 2021;9(8):873-884. doi:10.1016/S2213-2600(20)30504-X. IF:30,70.

Research highlights

PROJECTS

8 Competitive projects
1 4 Non competitive projects

86 Clinical trials

PUBLISHED WORKS

1 Clinical Guideline

INNOVATION

1 Spin-off

Selected projects

  • 20FIS038. EFECTO DE LORATADINA EN LINFANGIOLEIOMIOMATOSIS. (ICI19/00047). ISCIII. Importe Concedido:263.603,37€. 2020-2023. IP:MOLINA,MARIA.
  • 19FIS033. Caracterización de la fibrosis pulmonar telomérica y su regulación biológica. (PI18/00367). ISCIII. Importe Concedido:177.870,00€. 2019-2022. IP:MOLINA,MARIA.
  • 20FIS037. RAISING DIAGNOSTIC ACCURACY AND THERAPEUTIC PERSPECTIVES IN INTERSTITIAL LUNG DISEASES. (AC19/00006). ISCIII. Importe Concedido:99.825,00€. 2020-2022. IP:MOLINA,MARIA.
  • 21FIS005. Inflamación eosinofílica purinérgica en enfermedades obstructivas crónicas de la vía aérea (Asma y EPOC). (PI20/00777). ISCIII. Importe Concedido:87.120,00€. 2021-2023. IP:MUÑOZ ESQUERRE,MARIANA MERCEDES.
  • FIS21133. CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (CIBER). (CB21/06/00007). ISCIII. Importe Concedido:65.300,00€. 2021-2022. IP:MOLINA,MARIA.